基于中医传承辅助系统挖掘三期辨证指导下中医治疗骨质疏松性骨折的用药规律

doi:10.20047/j.issn1673-7210.2023.20.06

Abstract
Figure/Table
References (24)
Related Citation (15)

Download: PDF (1072 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To explore the medication rule of traditional Chinese medicine for osteoporotic fracture under the theory of three-stage syndrome differentiation, and to provide reference for clinical treatment of osteoporotic fracture. Methods Through CNKI, Wanfang Data, and VIP, literatures related to the use of traditional Chinese medicine prescriptions in the treatment of osteoporotic fractures from inception to May 2022 was collected, prescription data were screened and sorted out, and standardized processing was carried out. The traditional Chinese medicine inheritance support system system (V 2.5) was used to conduct drug classification, normalization of nature and flavour, formula composition rule, and entropy cluster analysis. Results After retrieval and removal, 2 009 articles were included, including 100 prescriptions in the early stage, 95 in the middle stage, and 95 in the late stage. In the early stage of osteoporotic fracture, the most frequently used drug was Fos Carthami, and the most frequently used drugs were Radix Angelicae Sinensis and Cortex Eucommiae in the middle and late stage. In three-stage, the four nature of drugs were mainly warm, cold, clam, and the five flavour of drugs were mainly sweet, bitter, and pungent. Liver, kidney, spleen, and heart channels with high frequency of meridian conversion were developed, and six common drug pairs and three new prescriptions were obtained. Conclusion Clinical treatment of osteoporotic fracture can be based on the three-stage syndrome differentiation, flexible use the drugs of promoting blood circulation for removing blood stasis, relieving pain and harmonizing ying, nourishing liver and kidney, replenishing qi and blood, improve the effect of Chinese medicine treatment.

Key words： Osteoporotic fracture Three-stage syndrome differentiation Data mining Traditional Chinese medicine inheritance support system

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	DU Mengfan1 CHEN Can1 CHEN Yiren1 GUO Shuang1 ZHAO Yu1 ZHANG Yan2 LIU Junning2 NIU Susheng2

Cite this article:

DU Mengfan1 CHEN Can1 CHEN Yiren1 GUO Shuang1 ZHAO Yu1 ZHANG Yan2 LIU Junning2 NIU Susheng2. Mining medication law of traditional Chinese medicine treatment of osteoporotic fracture under the guidance of three-stage syndrome differentiation based on traditional Chinese medicine inheritance support system[J]. 中国医药导报, 2023, 20(20): 34-38.

URL:

https://www.yiyaodaobao.com.cn/EN/10.20047/j.issn1673-7210.2023.20.06 OR https://www.yiyaodaobao.com.cn/EN/Y2023/V20/I20/34

[1] 中华医学会骨科学分会.骨质疏松性骨折诊疗指南（2022年版）[J].中华骨科杂志，2022，42（22）：1473-1491.
[2] Compston J. Obesity and fractures in postmenopausal women [J]. Curr Opin Rheumatol，2015，27（4）：414-419.
[3] 赵高伟，石新成，王红千.双骨三子胶囊联合骨化三醇治疗女性绝经后骨质疏松性髋部骨折的临床研究[J].现代药物与临床，2022，37（6）：1310-1314.
[4] 史晓林，刘康.骨质疏松性骨折中医诊疗指南[J].中国骨质疏松杂志，2022：1-16.
[5] 孙绍裘.孙达武骨伤科学术经验集[M].北京：人民军医出版社，2015.
[6] 中国中西医结合学会骨伤科专业委员会.骨质疏松症中西医结合诊疗指南[J].中华医学杂志，2019（45）：3524- 3525.
[7] 中华人民共和国卫生部药典委员会.中华人民共和国药典[M].一部.北京：人民卫生出版社，1990.
[8] 钟赣生.中药学[M].北京：中国中医药出版社，2016.
[9] 王嘉欣，姚鉴玲，马嘉慕，等.基于AHP-SOM聚类-TOPSIS和中医传承辅助平台研究中医药治疗围绝经期抑郁症组方规律[J].中草药，2022，53（22）：7153-7163.
[10] 宋芬芬，罗琼，刘季元，等.基于中医传承辅助平台探析张争昌治疗急性期热性面瘫选穴经验[J].现代中医药，2022，42（5）：93-97.
[11] 陈晓虹，沈慧，夏杰琼.中老年人骨质疏松性骨折流行病学特点及相关因素[J].中国老年学杂志，2016，36（13）： 3299-3301.
[12] Rozen N，Lewinson D，Bick T，et al. Role of bone regeneration and turnover modulators in control of fracture [J]. Crit Rev Eukaryot Gene Expr，2007，17（3）：197-213.
[13] 范文娟，曾春华，焦闪云.自我超越理论护理对骨质疏松性骨折患者术后康复、心理痛苦程度的影响[J].国际护理学杂志，2022，41（19）：3540-3544.
[14] 胡军，张华，牟青.骨质疏松症的流行病学趋势与防治进展[J].临床荟萃，2011，26（8）：729-731.
[15] 杨朝旭，邢栋，张隆，等.老年骨质疏松性骨折术后再骨折的流行病学调查[J].中国骨与关节损伤杂志，2022， 37（3）：277-279.
[16] Chen L，Yang L，Yao M，et al. Biomechanical Characteristics of Osteoporotic Fracture Healing in Ovariectomized Rats：A Systematic Review [J]. PLoS One，2016，11（4）：e0153120.
[17] Zhang H，Hu Y，Chen X，et al. Expert consensus on the bone repair strategy for osteoporotic fractures in China [J]. Front Endocrinol（Lausanne），2022，13：989648.
[18] 阙再忠，孙承禄.中医骨伤科古医籍选[M].北京：人民卫生出版社，1998.
[19] 陈智能，徐杰，叶俊材，等.三期辨证中药复方对老年性骨质疏松髋部骨折患者骨代谢标志物的影响[J].中华中医药杂志，2018，33（7）：3196-3199.
[20] 刘柏龄，邓福树.中医骨伤科各家学说[M].北京：人民卫生出版社，1998.
[21] 李汪洋，熊辉.桃红四物汤早期干预对大鼠骨折愈合中间充质干细胞归巢的影响[J].中国骨伤，2022，35（4）：367-374.
[22] 白万辉，赵勇，王旋，等.桃红四物汤治疗骨质疏松性骨折的网络药理学和分子对接研究[J].中国骨质疏松杂志，2022，28（5）：689-694.
[23] 李志鸿，叶学劲，刘经鹏，等.当归-骨碎补配伍治疗骨折三期辨证中期的网络药理学机制[J].广州中医药大学学报，2021，38（8）：1693-1699.
[24] 李楠，莫文.骨伤内伤学[M].北京：人民卫生出版社，2021.